ALLMedicine™ Lymphomatoid Papulosis Center
Research & Reviews 137 results
https://doi.org/10.1097/DAD.0000000000002219
The American Journal of Dermatopathology; Knapp C, Steele E et. al.
May 4th, 2022 - Janus kinase (JAK) inhibitors are being prescribed with increasing regularity in dermatology. We report on a patient who initiated treatment with tofacitinib for refractory erythema elevatum diutinum and subsequently developed a novel cutaneous ou...
https://doi.org/10.1016/j.clml.2022.02.004
Clinical Lymphoma, Myeloma & Leukemia; Jung JM, Lee MY et. al.
Mar 22nd, 2022 - The clinical and pathological features of lymphomatoid papulosis (LYP) are diverse. The objective of this study is to evaluate the clinical and pathological features associated with the prognosis and clinical course of LYP. The clinical and pathol...
https://doi.org/10.1097/DAD.0000000000002063
The American Journal of Dermatopathology; Brem CE, Abbas O et. al.
Feb 17th, 2022 - Pityriasis lichenoides et varioliformis acuta (PLEVA) and lymphomatoid papulosis (LyP) can often demonstrate clinical and histopathologic overlap. A recent study demonstrated significant plasmacytoid dendritic cell (pDC) recruitment in lesions of ...
https://doi.org/10.1177/12034754221077694
Journal of Cutaneous Medicine and Surgery; Colmant C, Demers MA et. al.
Feb 16th, 2022 - Cutaneous hematologic malignancies are rare in children, and the literature about them is still sparse. The purpose of our study was to report our experience with pediatric cases of cutaneous hematologic disorders and describe their clinical and h...
https://doi.org/10.1111/cup.14199
Journal of Cutaneous Pathology; Travassos DC, Silveira HA et. al.
Jan 11th, 2022 - The primary cutaneous (PC) CD8+ T-cell lymphoproliferative disorders (LPDs) comprise clinically and histopathologically heterogeneous entities including mycosis fungoides, lymphomatoid papulosis, hydroa-vacciniforme-like LPD, subcutaneous pannicul...
Clinicaltrials.gov 1 results
https://clinicaltrials.gov/ct2/show/NCT01352520
Nov 12th, 2021 - The Study Drug: Brentuximab vedotin is an antibody that is designed to find a certain protein (called CD30) on cancer cells and bind to it. It is designed to then enter the cell and release a molecule that may kill the cancer cells. Study Drug Adm...
News 13 results
https://www.mdedge.com/dermatology/article/241494/dermatopathology/atrophic-lesions-pregnant-woman
Santana D. VanDyke, MD, Darren J. Guffey, MD et. al.
Jun 14th, 2021 - The Diagnosis: Degos Disease The pathophysiology of Degos disease (malignant atrophic papulosis) is unknown. 1 Histopathology demonstrates a wedge-shaped area of dermal necrosis with edema and mucin deposition extending from the papillary dermis to.
https://www.mdedge.com/dermatology/article/217287/medical-dermatology/make-diagnosis-march-2020?channel=39212
Donna Bilu Martin, MD
Feb 13th, 2020 - The patient’s biopsy showed sparse and grouped and slightly enlarged atypical stained mononuclear cells in mostly perifollicular areas with focal epidermotropism. CD30 staining was positive.
https://www.mdedge.com/dermatology/article/217287/medical-dermatology/make-diagnosis-march-2020
Donna Bilu Martin, MD
Feb 13th, 2020 - The patient’s biopsy showed sparse and grouped and slightly enlarged atypical stained mononuclear cells in mostly perifollicular areas with focal epidermotropism. CD30 staining was positive.
https://www.mdedge.com/pediatrics/article/210130/dermatology/pruritic-pink-violaceous-scaly-papules
Catalina Matiz, MD
Oct 15th, 2019 - A skin biopsy of one of the lesions was consistent with pityriasis lichenoides et varioliformis acuta (PLEVA). Dr.
https://www.mdedge.com/dermatology/article/206560/mixed-topics/lamotrigine-induced-cutaneous-pseudolymphoma/page/0/1?channel=44
Aug 16th, 2019 - The clinical appearance of cutaneous pseudolymphoma is variable, ranging from discrete nodules or papules to even confluent erythroderma in certain cases. 2 The high clinical variability further complicates diagnosis.